JW Holdings Corporation

KOSE:A096760 Stock Report

Market Cap: ₩217.7b

JW Holdings Past Earnings Performance

Past criteria checks 5/6

JW Holdings has been growing earnings at an average annual rate of 62.3%, while the Pharmaceuticals industry saw earnings growing at 7.5% annually. Revenues have been growing at an average rate of 5.6% per year. JW Holdings's return on equity is 30.8%, and it has net margins of 7.4%.

Key information

62.3%

Earnings growth rate

62.5%

EPS growth rate

Pharmaceuticals Industry Growth11.3%
Revenue growth rate5.6%
Return on equity30.8%
Net Margin7.4%
Last Earnings Update30 Sep 2024

Recent past performance updates

JW Holdings' (KRX:096760) Soft Earnings Are Actually Better Than They Appear

Mar 25
JW Holdings' (KRX:096760) Soft Earnings Are Actually Better Than They Appear

Shareholders Can Be Confident That JW Holdings' (KRX:096760) Earnings Are High Quality

Apr 01
Shareholders Can Be Confident That JW Holdings' (KRX:096760) Earnings Are High Quality

Recent updates

Cautious Investors Not Rewarding JW Holdings Corporation's (KRX:096760) Performance Completely

Sep 20
Cautious Investors Not Rewarding JW Holdings Corporation's (KRX:096760) Performance Completely

JW Holdings Corporation's (KRX:096760) Shareholders Might Be Looking For Exit

Jun 14
JW Holdings Corporation's (KRX:096760) Shareholders Might Be Looking For Exit

JW Holdings' (KRX:096760) Soft Earnings Are Actually Better Than They Appear

Mar 25
JW Holdings' (KRX:096760) Soft Earnings Are Actually Better Than They Appear

Shareholders Can Be Confident That JW Holdings' (KRX:096760) Earnings Are High Quality

Apr 01
Shareholders Can Be Confident That JW Holdings' (KRX:096760) Earnings Are High Quality

Would Shareholders Who Purchased JW Holdings' (KRX:096760) Stock Three Years Be Happy With The Share price Today?

Mar 15
Would Shareholders Who Purchased JW Holdings' (KRX:096760) Stock Three Years Be Happy With The Share price Today?

Is JW Holdings (KRX:096760) Using Too Much Debt?

Feb 15
Is JW Holdings (KRX:096760) Using Too Much Debt?

What Type Of Shareholders Make Up JW Holdings Corporation's (KRX:096760) Share Registry?

Jan 20
What Type Of Shareholders Make Up JW Holdings Corporation's (KRX:096760) Share Registry?

Do These 3 Checks Before Buying JW Holdings Corporation (KRX:096760) For Its Upcoming Dividend

Dec 24
Do These 3 Checks Before Buying JW Holdings Corporation (KRX:096760) For Its Upcoming Dividend

Read This Before Buying JW Holdings Corporation (KRX:096760) For Its Dividend

Dec 06
Read This Before Buying JW Holdings Corporation (KRX:096760) For Its Dividend

Revenue & Expenses Breakdown

How JW Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSE:A096760 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24925,72868,224229,93242,722
30 Jun 24915,74057,639234,26837,854
31 Mar 24934,66014,423256,29935,165
31 Dec 23928,07219,026249,62333,734
30 Sep 23907,45513,382244,36431,870
30 Jun 23908,42819,650245,77735,309
31 Mar 23880,02933,135233,15433,262
31 Dec 22864,53622,152240,61433,148
30 Sep 22854,9883,861256,61527,046
30 Jun 22815,391-497246,03118,944
31 Mar 22800,272-2,781249,68218,410
31 Dec 21788,937-2,778249,16017,760
30 Sep 21758,79221,163241,10818,179
30 Jun 21780,91417,459242,38822,165
31 Mar 21783,85617,527230,78922,793
31 Dec 20781,5159,064229,01023,127
30 Sep 20753,452-24,454233,06621,226
30 Jun 20743,994-23,576235,39221,783
31 Mar 20737,324-22,655237,92123,238
31 Dec 19728,082-28,676242,48022,402
30 Sep 19728,869-7,507241,82121,397
30 Jun 19732,685-26,022247,06120,239
31 Mar 19722,599-26,837250,34117,028
31 Dec 18725,382-20,090248,77917,899
30 Sep 18695,347-27,907238,67418,520
30 Jun 18681,053-12,269229,54920,418
31 Mar 18678,729-6,907225,79923,125
31 Dec 17681,16455,659219,49224,018
30 Sep 17697,51957,333218,66623,373
30 Jun 17692,69662,488219,23423,090
31 Mar 17696,45052,590211,07220,869
31 Dec 16684,839-8,663207,97420,458
30 Sep 16679,680-3,037204,28620,056
30 Jun 16665,117-7,153203,82619,610
31 Mar 16648,584537200,43619,601
31 Dec 15622,825181194,26918,591
30 Sep 15632,128-3,036206,12018,831
30 Jun 15612,284-2,747197,64018,804
31 Mar 15593,142-7,121192,14719,670
31 Dec 14573,935-10,940187,81420,056
30 Sep 14538,822-9,883171,34719,723
30 Jun 14531,509-14,600169,82418,624
31 Mar 14527,41516,797172,15317,435
31 Dec 13530,26317,817173,98216,301

Quality Earnings: A096760 has high quality earnings.

Growing Profit Margin: A096760's current net profit margins (7.4%) are higher than last year (1.5%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A096760 has become profitable over the past 5 years, growing earnings by 62.3% per year.

Accelerating Growth: A096760's earnings growth over the past year (409.8%) exceeds its 5-year average (62.3% per year).

Earnings vs Industry: A096760 earnings growth over the past year (409.8%) exceeded the Pharmaceuticals industry 22.3%.

Return on Equity

High ROE: Whilst A096760's Return on Equity (30.79%) is high, this metric is skewed due to their high level of debt.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 06:19
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

JW Holdings Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jayaprabha DhavaleVirtua Research Inc.